drugset

drugset / Trial / NCT04047186

Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules

NCT04047186 ↗

Phase 2 Completed 12 enrolled XiangNing Fu

NaSingle-groupOpen-labelTreatment

Summary

Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules: a pilot study

Timeline

Start: 2019-07-01
Primary completion: 2024-12-31
Completion: 2025-05-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tislelizumab	Monoclonal antibody	—	—

Indications